| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 9.58e-06 | 188 | 15 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 3.46e-05 | 12 | 15 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 4.77e-05 | 14 | 15 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.61e-04 | 749 | 15 | 5 | GO:0005509 | |
| GeneOntologyMolecularFunction | structural molecule activity | 3.62e-03 | 891 | 15 | 4 | GO:0005198 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 6.33e-03 | 161 | 15 | 2 | GO:0051087 | |
| GeneOntologyMolecularFunction | integrin binding | 7.44e-03 | 175 | 15 | 2 | GO:0005178 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 1.08e-04 | 131 | 15 | 3 | GO:0030510 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 1.35e-04 | 24 | 15 | 2 | GO:1905146 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.77e-04 | 410 | 15 | 4 | GO:0031589 | |
| GeneOntologyBiologicalProcess | protein catabolic process in the vacuole | 1.85e-04 | 28 | 15 | 2 | GO:0007039 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 2.08e-04 | 817 | 15 | 5 | GO:0048514 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 3.59e-04 | 197 | 15 | 3 | GO:0030509 | |
| GeneOntologyBiologicalProcess | blood vessel development | 3.77e-04 | 929 | 15 | 5 | GO:0001568 | |
| GeneOntologyBiologicalProcess | positive regulation of BMP signaling pathway | 4.18e-04 | 42 | 15 | 2 | GO:0030513 | |
| GeneOntologyBiologicalProcess | vasculature development | 4.58e-04 | 969 | 15 | 5 | GO:0001944 | |
| GeneOntologyBiologicalProcess | response to BMP | 4.63e-04 | 215 | 15 | 3 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 4.63e-04 | 215 | 15 | 3 | GO:0071773 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 5.86e-04 | 233 | 15 | 3 | GO:0061351 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 8.98e-04 | 270 | 15 | 3 | GO:0007160 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 9.07e-04 | 1125 | 15 | 5 | GO:0035239 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | 9.37e-04 | 1133 | 15 | 5 | GO:0043066 | |
| GeneOntologyBiologicalProcess | axon development | 9.65e-04 | 642 | 15 | 4 | GO:0061564 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.05e-03 | 285 | 15 | 3 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.06e-03 | 286 | 15 | 3 | GO:0097485 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | 1.09e-03 | 1171 | 15 | 5 | GO:0043069 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | 1.17e-03 | 1190 | 15 | 5 | GO:0008284 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.19e-03 | 71 | 15 | 2 | GO:0002347 | |
| GeneOntologyBiologicalProcess | angiogenesis | 1.39e-03 | 708 | 15 | 4 | GO:0001525 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic process | 1.46e-03 | 718 | 15 | 4 | GO:0043065 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte activation | 1.47e-03 | 320 | 15 | 3 | GO:0002274 | |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 1.51e-03 | 80 | 15 | 2 | GO:2000179 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 1.55e-03 | 81 | 15 | 2 | GO:0043030 | |
| GeneOntologyBiologicalProcess | positive regulation of programmed cell death | 1.63e-03 | 739 | 15 | 4 | GO:0043068 | |
| GeneOntologyBiologicalProcess | neuron projection development | 1.65e-03 | 1285 | 15 | 5 | GO:0031175 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 1.66e-03 | 334 | 15 | 3 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 1.66e-03 | 334 | 15 | 3 | GO:0001894 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.85e-03 | 347 | 15 | 3 | GO:0090092 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 1.86e-03 | 89 | 15 | 2 | GO:0060411 | |
| GeneOntologyBiologicalProcess | cellular oxidant detoxification | 2.34e-03 | 100 | 15 | 2 | GO:0098869 | |
| GeneOntologyBiologicalProcess | tube development | 2.43e-03 | 1402 | 15 | 5 | GO:0035295 | |
| GeneOntologyBiologicalProcess | defense response to other organism | 2.47e-03 | 1407 | 15 | 5 | GO:0098542 | |
| GeneOntologyBiologicalProcess | circulatory system development | 2.75e-03 | 1442 | 15 | 5 | GO:0072359 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | 2.87e-03 | 405 | 15 | 3 | GO:0042742 | |
| GeneOntologyBiologicalProcess | neuron development | 2.93e-03 | 1463 | 15 | 5 | GO:0048666 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 3.01e-03 | 412 | 15 | 3 | GO:0090287 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.09e-03 | 115 | 15 | 2 | GO:0090100 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 3.11e-03 | 1483 | 15 | 5 | GO:0048646 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 3.14e-03 | 116 | 15 | 2 | GO:0045670 | |
| GeneOntologyBiologicalProcess | gliogenesis | 3.51e-03 | 435 | 15 | 3 | GO:0042063 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 3.74e-03 | 445 | 15 | 3 | GO:0141091 | |
| GeneOntologyBiologicalProcess | bone remodeling | 3.75e-03 | 127 | 15 | 2 | GO:0046849 | |
| GeneOntologyBiologicalProcess | cellular detoxification | 3.75e-03 | 127 | 15 | 2 | GO:1990748 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 4.16e-03 | 134 | 15 | 2 | GO:0003279 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 4.22e-03 | 135 | 15 | 2 | GO:2000177 | |
| GeneOntologyBiologicalProcess | cellular response to toxic substance | 4.47e-03 | 139 | 15 | 2 | GO:0097237 | |
| GeneOntologyBiologicalProcess | macrophage activation | 4.53e-03 | 140 | 15 | 2 | GO:0042116 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 4.68e-03 | 482 | 15 | 3 | GO:0007178 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.50e-07 | 656 | 15 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.53e-07 | 658 | 15 | 7 | GO:0030312 | |
| GeneOntologyCellularComponent | Golgi lumen | 5.99e-05 | 109 | 15 | 3 | GO:0005796 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.46e-04 | 530 | 15 | 4 | GO:0062023 | |
| MousePheno | abnormal response/metabolism to endogenous compounds | 1.96e-06 | 104 | 13 | 4 | MP:0003638 | |
| MousePheno | abnormal respiratory system physiology | 7.97e-05 | 897 | 13 | 6 | MP:0002133 | |
| MousePheno | abnormal skin morphology | 1.27e-04 | 1455 | 13 | 7 | MP:0002060 | |
| MousePheno | abnormal ear physiology | 2.56e-04 | 684 | 13 | 5 | MP:0003878 | |
| MousePheno | abnormal induced morbidity/mortality | 3.63e-04 | 737 | 13 | 5 | MP:0001657 | |
| MousePheno | emphysema | 5.22e-04 | 37 | 13 | 2 | MP:0001958 | |
| MousePheno | increased susceptibility to infection induced morbidity/mortality | 5.92e-04 | 185 | 13 | 3 | MP:0009787 | |
| MousePheno | abnormal interleukin-6 secretion | 6.01e-04 | 186 | 13 | 3 | MP:0008704 | |
| MousePheno | ear inflammation | 6.10e-04 | 40 | 13 | 2 | MP:0001849 | |
| MousePheno | abnormal inflammatory response | 6.44e-04 | 1310 | 13 | 6 | MP:0001845 | |
| MousePheno | abnormal interleukin secretion | 7.55e-04 | 478 | 13 | 4 | MP:0008568 | |
| MousePheno | abnormal kidney morphology | 7.97e-04 | 1363 | 13 | 6 | MP:0002135 | |
| MousePheno | increased susceptibility to infection | 9.21e-04 | 504 | 13 | 4 | MP:0002406 | |
| MousePheno | hearing/vestibular/ear phenotype | 9.34e-04 | 905 | 13 | 5 | MP:0005377 | |
| Domain | EGF | 1.29e-14 | 235 | 14 | 9 | SM00181 | |
| Domain | EGF-like_dom | 2.18e-14 | 249 | 14 | 9 | IPR000742 | |
| Domain | EGF_1 | 2.70e-14 | 255 | 14 | 9 | PS00022 | |
| Domain | EGF-like_CS | 3.34e-14 | 261 | 14 | 9 | IPR013032 | |
| Domain | EGF_2 | 3.83e-14 | 265 | 14 | 9 | PS01186 | |
| Domain | EGF_3 | 1.45e-10 | 235 | 14 | 7 | PS50026 | |
| Domain | TIL_dom | 1.97e-10 | 14 | 14 | 4 | IPR002919 | |
| Domain | VWFD | 3.58e-10 | 16 | 14 | 4 | PS51233 | |
| Domain | VWD | 3.58e-10 | 16 | 14 | 4 | SM00216 | |
| Domain | VWF_type-D | 3.58e-10 | 16 | 14 | 4 | IPR001846 | |
| Domain | VWD | 3.58e-10 | 16 | 14 | 4 | PF00094 | |
| Domain | Growth_fac_rcpt_ | 7.18e-08 | 156 | 14 | 5 | IPR009030 | |
| Domain | C8 | 9.55e-08 | 13 | 14 | 3 | SM00832 | |
| Domain | Unchr_dom_Cys-rich | 9.55e-08 | 13 | 14 | 3 | IPR014853 | |
| Domain | VWC_out | 3.23e-07 | 19 | 14 | 3 | SM00215 | |
| Domain | EGF_CA | 4.05e-07 | 86 | 14 | 4 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 6.58e-07 | 97 | 14 | 4 | IPR018097 | |
| Domain | EGF_CA | 7.14e-07 | 99 | 14 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.43e-07 | 100 | 14 | 4 | PS00010 | |
| Domain | cEGF | 8.63e-07 | 26 | 14 | 3 | PF12662 | |
| Domain | cEGF | 8.63e-07 | 26 | 14 | 3 | IPR026823 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.39e-07 | 106 | 14 | 4 | IPR000152 | |
| Domain | EGF_CA | 1.65e-06 | 122 | 14 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.76e-06 | 124 | 14 | 4 | IPR001881 | |
| Domain | EGF | 1.88e-06 | 126 | 14 | 4 | PF00008 | |
| Domain | VWC | 2.78e-06 | 38 | 14 | 3 | SM00214 | |
| Domain | VWF_dom | 3.78e-06 | 42 | 14 | 3 | IPR001007 | |
| Domain | TIL | 3.43e-05 | 12 | 14 | 2 | PF01826 | |
| Domain | C8 | 3.43e-05 | 12 | 14 | 2 | PF08742 | |
| Domain | VWC | 1.95e-04 | 28 | 14 | 2 | PF00093 | |
| Domain | VWFC_1 | 3.24e-04 | 36 | 14 | 2 | PS01208 | |
| Domain | VWFC_2 | 3.61e-04 | 38 | 14 | 2 | PS50184 | |
| Domain | EGF_extracell | 9.01e-04 | 60 | 14 | 2 | IPR013111 | |
| Domain | EGF_2 | 9.01e-04 | 60 | 14 | 2 | PF07974 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 3.41e-07 | 16 | 13 | 3 | M27410 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.43e-07 | 68 | 13 | 4 | M27303 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 4.14e-07 | 17 | 13 | 3 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.07e-06 | 23 | 13 | 3 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.57e-06 | 26 | 13 | 3 | M27483 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 6.76e-06 | 143 | 13 | 4 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.25e-05 | 62 | 13 | 3 | M546 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 6.09e-05 | 250 | 13 | 4 | M27554 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.24e-04 | 300 | 13 | 4 | M610 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.28e-04 | 111 | 13 | 3 | M27416 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.63e-04 | 21 | 13 | 2 | MM15706 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.55e-04 | 140 | 13 | 3 | M27484 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.83e-04 | 32 | 13 | 2 | MM14854 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 5.13e-04 | 37 | 13 | 2 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 5.71e-04 | 39 | 13 | 2 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.27e-04 | 44 | 13 | 2 | M26969 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.35e-03 | 60 | 13 | 2 | MM15636 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.51e-03 | 258 | 13 | 3 | MM14572 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 2.43e-03 | 1128 | 13 | 5 | M1036 | |
| Pathway | WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME | 4.14e-03 | 106 | 13 | 2 | M40052 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.37e-03 | 109 | 13 | 2 | MM15164 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 7.11e-03 | 140 | 13 | 2 | M587 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 5.28e-08 | 18 | 15 | 3 | 18834073 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 12931033 | ||
| Pubmed | Role of Fibulins 2 and 5 in Retinal Development and Maintenance. | 1.74e-07 | 2 | 15 | 2 | 29721953 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 19893004 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 14690056 | ||
| Pubmed | Mapping of the glycoprotein 330 (Gp330) gene to mouse chromosome 2. | 5.21e-07 | 3 | 15 | 2 | 8244399 | |
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 12618961 | ||
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 15610515 | ||
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 1.73e-06 | 5 | 15 | 2 | 11062147 | |
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 11733994 | ||
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 19349279 | ||
| Pubmed | Molecular evolution of the fibulins: implications on the functionality of the elastic fibulins. | 2.60e-06 | 6 | 15 | 2 | 20595023 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 3.30e-06 | 1070 | 15 | 6 | 23533145 | |
| Pubmed | M phase-specific association of human topoisomerase IIIbeta with chromosomes. | 4.85e-06 | 8 | 15 | 2 | 11549288 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 5.03e-06 | 79 | 15 | 3 | 18757743 | |
| Pubmed | 1.14e-05 | 12 | 15 | 2 | 8631881 | ||
| Pubmed | 3.65e-05 | 153 | 15 | 3 | 25037231 | ||
| Pubmed | 3.99e-05 | 22 | 15 | 2 | 10438476 | ||
| Pubmed | 3.99e-05 | 22 | 15 | 2 | 12768436 | ||
| Pubmed | 4.74e-05 | 167 | 15 | 3 | 22159717 | ||
| Pubmed | 5.45e-05 | 175 | 15 | 3 | 28071719 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 7.88e-05 | 560 | 15 | 4 | 21653829 | |
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 1.02e-04 | 35 | 15 | 2 | 21252157 | |
| Pubmed | 1.08e-04 | 608 | 15 | 4 | 16713569 | ||
| Pubmed | 1.34e-04 | 40 | 15 | 2 | 23362348 | ||
| Pubmed | 1.41e-04 | 41 | 15 | 2 | 16740002 | ||
| Pubmed | 1.41e-04 | 41 | 15 | 2 | 22675208 | ||
| Pubmed | 1.48e-04 | 42 | 15 | 2 | 18985028 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.53e-04 | 248 | 15 | 3 | 24006456 | |
| Pubmed | 1.86e-04 | 47 | 15 | 2 | 11208732 | ||
| Pubmed | 1.94e-04 | 48 | 15 | 2 | 35247391 | ||
| Interaction | ZNF408 interactions | 5.10e-08 | 145 | 15 | 5 | int:ZNF408 | |
| Interaction | ZFP41 interactions | 7.67e-08 | 57 | 15 | 4 | int:ZFP41 | |
| Interaction | ZNF235 interactions | 9.50e-08 | 13 | 15 | 3 | int:ZNF235 | |
| Interaction | IGFL3 interactions | 2.34e-07 | 75 | 15 | 4 | int:IGFL3 | |
| Interaction | ZNF627 interactions | 3.77e-07 | 20 | 15 | 3 | int:ZNF627 | |
| Interaction | NTN5 interactions | 6.69e-07 | 24 | 15 | 3 | int:NTN5 | |
| Interaction | FBLN1 interactions | 2.07e-06 | 129 | 15 | 4 | int:FBLN1 | |
| Interaction | ZNF324 interactions | 4.97e-06 | 46 | 15 | 3 | int:ZNF324 | |
| Interaction | ZNF865 interactions | 5.30e-06 | 47 | 15 | 3 | int:ZNF865 | |
| Interaction | ATN1 interactions | 9.05e-06 | 187 | 15 | 4 | int:ATN1 | |
| Interaction | ZNF594 interactions | 1.08e-05 | 7 | 15 | 2 | int:ZNF594 | |
| Interaction | ZNF253 interactions | 1.08e-05 | 7 | 15 | 2 | int:ZNF253 | |
| Interaction | ZNF696 interactions | 1.62e-05 | 68 | 15 | 3 | int:ZNF696 | |
| Interaction | EGFL7 interactions | 2.36e-05 | 77 | 15 | 3 | int:EGFL7 | |
| Interaction | LPA interactions | 2.83e-05 | 11 | 15 | 2 | int:LPA | |
| Interaction | ZNF709 interactions | 4.01e-05 | 13 | 15 | 2 | int:ZNF709 | |
| Interaction | LTBP1 interactions | 4.03e-05 | 92 | 15 | 3 | int:LTBP1 | |
| Interaction | ZNF407 interactions | 4.68e-05 | 14 | 15 | 2 | int:ZNF407 | |
| Interaction | AGRP interactions | 4.68e-05 | 14 | 15 | 2 | int:AGRP | |
| Interaction | ZNF628 interactions | 6.17e-05 | 16 | 15 | 2 | int:ZNF628 | |
| Interaction | SULF2 interactions | 8.67e-05 | 119 | 15 | 3 | int:SULF2 | |
| Interaction | ZNF358 interactions | 8.78e-05 | 19 | 15 | 2 | int:ZNF358 | |
| Interaction | ZSCAN21 interactions | 1.08e-04 | 128 | 15 | 3 | int:ZSCAN21 | |
| Interaction | ZNF142 interactions | 1.08e-04 | 21 | 15 | 2 | int:ZNF142 | |
| Interaction | ZNF77 interactions | 1.18e-04 | 22 | 15 | 2 | int:ZNF77 | |
| Interaction | ZNF282 interactions | 1.30e-04 | 23 | 15 | 2 | int:ZNF282 | |
| Interaction | ZNF765 interactions | 1.41e-04 | 24 | 15 | 2 | int:ZNF765 | |
| Interaction | CXCL5 interactions | 1.80e-04 | 27 | 15 | 2 | int:CXCL5 | |
| Interaction | ZNF320 interactions | 1.80e-04 | 27 | 15 | 2 | int:ZNF320 | |
| Interaction | EMILIN2 interactions | 1.80e-04 | 27 | 15 | 2 | int:EMILIN2 | |
| Interaction | OTX1 interactions | 1.90e-04 | 155 | 15 | 3 | int:OTX1 | |
| Interaction | FBXO2 interactions | 1.95e-04 | 411 | 15 | 4 | int:FBXO2 | |
| Interaction | ZNF517 interactions | 2.08e-04 | 29 | 15 | 2 | int:ZNF517 | |
| Interaction | ZNF430 interactions | 2.08e-04 | 29 | 15 | 2 | int:ZNF430 | |
| Interaction | LAMC2 interactions | 2.22e-04 | 30 | 15 | 2 | int:LAMC2 | |
| Interaction | CILP2 interactions | 2.37e-04 | 31 | 15 | 2 | int:CILP2 | |
| Interaction | ZNF664 interactions | 2.37e-04 | 31 | 15 | 2 | int:ZNF664 | |
| Interaction | ZNF136 interactions | 3.21e-04 | 36 | 15 | 2 | int:ZNF136 | |
| Interaction | ZNF724 interactions | 3.21e-04 | 36 | 15 | 2 | int:ZNF724 | |
| Interaction | GREM2 interactions | 3.39e-04 | 37 | 15 | 2 | int:GREM2 | |
| Interaction | ZNF747 interactions | 3.97e-04 | 40 | 15 | 2 | int:ZNF747 | |
| Interaction | POLRMT interactions | 4.69e-04 | 211 | 15 | 3 | int:POLRMT | |
| Interaction | ZNF316 interactions | 5.25e-04 | 46 | 15 | 2 | int:ZNF316 | |
| Interaction | NID1 interactions | 5.72e-04 | 48 | 15 | 2 | int:NID1 | |
| Interaction | SMOC1 interactions | 7.24e-04 | 54 | 15 | 2 | int:SMOC1 | |
| Interaction | ZNF518A interactions | 7.24e-04 | 54 | 15 | 2 | int:ZNF518A | |
| Interaction | ZNF92 interactions | 7.51e-04 | 55 | 15 | 2 | int:ZNF92 | |
| Interaction | SENP5 interactions | 8.63e-04 | 59 | 15 | 2 | int:SENP5 | |
| Interaction | HRG interactions | 9.84e-04 | 63 | 15 | 2 | int:HRG | |
| Interaction | FBLN2 interactions | 1.08e-03 | 66 | 15 | 2 | int:FBLN2 | |
| Interaction | LTBP4 interactions | 1.11e-03 | 67 | 15 | 2 | int:LTBP4 | |
| Interaction | ZBTB44 interactions | 1.11e-03 | 67 | 15 | 2 | int:ZBTB44 | |
| Interaction | ZNF8 interactions | 1.21e-03 | 70 | 15 | 2 | int:ZNF8 | |
| Interaction | TAFA3 interactions | 1.50e-03 | 78 | 15 | 2 | int:TAFA3 | |
| Interaction | DUSP11 interactions | 1.66e-03 | 82 | 15 | 2 | int:DUSP11 | |
| Interaction | RBPMS2 interactions | 1.70e-03 | 83 | 15 | 2 | int:RBPMS2 | |
| Interaction | LGALS1 interactions | 1.74e-03 | 332 | 15 | 3 | int:LGALS1 | |
| Interaction | CST6 interactions | 1.99e-03 | 90 | 15 | 2 | int:CST6 | |
| Interaction | TIMP3 interactions | 1.99e-03 | 90 | 15 | 2 | int:TIMP3 | |
| Interaction | MDK interactions | 2.04e-03 | 91 | 15 | 2 | int:MDK | |
| Interaction | HOXA1 interactions | 2.12e-03 | 356 | 15 | 3 | int:HOXA1 | |
| Interaction | HSPG2 interactions | 2.36e-03 | 98 | 15 | 2 | int:HSPG2 | |
| Interaction | FAM76B interactions | 2.41e-03 | 99 | 15 | 2 | int:FAM76B | |
| Interaction | DLK1 interactions | 2.50e-03 | 101 | 15 | 2 | int:DLK1 | |
| Interaction | ZNF444 interactions | 2.75e-03 | 106 | 15 | 2 | int:ZNF444 | |
| Interaction | FNDC5 interactions | 3.32e-03 | 1470 | 15 | 5 | int:FNDC5 | |
| Interaction | NUFIP2 interactions | 3.33e-03 | 417 | 15 | 3 | int:NUFIP2 | |
| Interaction | LAMA5 interactions | 3.34e-03 | 117 | 15 | 2 | int:LAMA5 | |
| Interaction | ZBTB9 interactions | 3.34e-03 | 117 | 15 | 2 | int:ZBTB9 | |
| GeneFamily | CD molecules|Mucins | 1.61e-07 | 21 | 10 | 3 | 648 | |
| GeneFamily | Fibulins | 7.70e-06 | 8 | 10 | 2 | 556 | |
| Coexpression | NABA_MATRISOME | 2.35e-08 | 1008 | 15 | 8 | MM17056 | |
| Coexpression | NABA_MATRISOME | 2.70e-08 | 1026 | 15 | 8 | M5889 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.52e-08 | 191 | 15 | 5 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 3.08e-07 | 270 | 15 | 5 | MM17057 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 3.65e-06 | 193 | 15 | 4 | M39321 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.88e-06 | 196 | 15 | 4 | M3008 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 4.20e-06 | 200 | 15 | 4 | M5930 | |
| Coexpression | NABA_CORE_MATRISOME | 1.48e-05 | 275 | 15 | 4 | M5884 | |
| Coexpression | TRAVAGLINI_LUNG_MUCOUS_CELL | 4.62e-05 | 125 | 15 | 3 | M41656 | |
| Coexpression | SINGH_KRAS_DEPENDENCY_SIGNATURE | 5.77e-05 | 20 | 15 | 2 | M2851 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 5.77e-05 | 20 | 15 | 2 | MM17053 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 7.68e-05 | 23 | 15 | 2 | M48001 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.15e-04 | 170 | 15 | 3 | M5880 | |
| Coexpression | E2F1_UP.V1_DN | 1.53e-04 | 187 | 15 | 3 | M2630 | |
| Coexpression | GSE12366_GC_VS_NAIVE_BCELL_DN | 1.73e-04 | 195 | 15 | 3 | M3170 | |
| Coexpression | GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP | 1.75e-04 | 196 | 15 | 3 | M8683 | |
| Coexpression | GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN | 1.78e-04 | 197 | 15 | 3 | M3110 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.80e-04 | 35 | 15 | 2 | MM17054 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_NKCELL_UP | 1.81e-04 | 198 | 15 | 3 | M5420 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN | 1.86e-04 | 200 | 15 | 3 | M4506 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN | 1.86e-04 | 200 | 15 | 3 | M4496 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN | 1.86e-04 | 200 | 15 | 3 | M4480 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP | 1.86e-04 | 200 | 15 | 3 | M6620 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN | 1.86e-04 | 200 | 15 | 3 | M9588 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL | 2.47e-04 | 41 | 15 | 2 | M39158 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 2.92e-04 | 233 | 15 | 3 | M7094 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 2.92e-04 | 233 | 15 | 3 | M13273 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 2.99e-04 | 235 | 15 | 3 | M5311 | |
| Coexpression | DESCARTES_FETAL_EYE_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS | 3.34e-04 | 244 | 15 | 3 | M40175 | |
| Coexpression | BURTON_ADIPOGENESIS_7 | 3.54e-04 | 49 | 15 | 2 | M1616 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 3.69e-04 | 50 | 15 | 2 | M1259 | |
| Coexpression | WANG_BARRETTS_ESOPHAGUS_UP | 3.99e-04 | 52 | 15 | 2 | M6225 | |
| Coexpression | BURTON_ADIPOGENESIS_7 | 3.99e-04 | 52 | 15 | 2 | MM685 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_DC2_CELL | 3.99e-04 | 52 | 15 | 2 | M45724 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 3.99e-04 | 52 | 15 | 2 | MM1118 | |
| Coexpression | JAEGER_METASTASIS_DN | 4.02e-04 | 260 | 15 | 3 | M10702 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 4.34e-04 | 267 | 15 | 3 | MM1091 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 4.39e-04 | 268 | 15 | 3 | M45796 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | 4.78e-04 | 1242 | 15 | 5 | M1920 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 5.13e-04 | 59 | 15 | 2 | M47993 | |
| Coexpression | NADLER_OBESITY_UP | 5.31e-04 | 60 | 15 | 2 | M1431 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 5.47e-04 | 289 | 15 | 3 | M41750 | |
| Coexpression | JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN | 5.47e-04 | 289 | 15 | 3 | M38973 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL | 6.16e-04 | 301 | 15 | 3 | M45708 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 6.22e-04 | 302 | 15 | 3 | MM16604 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | 6.23e-04 | 1316 | 15 | 5 | MM1052 | |
| Coexpression | NADLER_OBESITY_UP | 6.61e-04 | 67 | 15 | 2 | MM1007 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 7.09e-04 | 751 | 15 | 4 | M5885 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP | 8.69e-04 | 339 | 15 | 3 | M34012 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_MESOTHELIAL_CELLS | 9.41e-04 | 80 | 15 | 2 | M40273 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 9.93e-04 | 355 | 15 | 3 | M45758 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | 1.03e-03 | 359 | 15 | 3 | M15193 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL | 1.38e-03 | 97 | 15 | 2 | M45794 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 8.94e-06 | 778 | 15 | 6 | gudmap_kidney_adult_RenalCapsule_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.78e-05 | 878 | 15 | 6 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.90e-05 | 265 | 15 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 3.19e-05 | 973 | 15 | 6 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | 3.40e-05 | 984 | 15 | 6 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.41e-05 | 276 | 15 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.59e-05 | 298 | 15 | 4 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 6.39e-05 | 655 | 15 | 5 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.83e-05 | 330 | 15 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 6.91e-05 | 331 | 15 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.06e-04 | 134 | 15 | 3 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.10e-04 | 734 | 15 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#2 | 1.39e-04 | 147 | 15 | 3 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K2 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 1.41e-04 | 398 | 15 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | colon | 1.75e-04 | 159 | 15 | 3 | colon | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#3 | 1.79e-04 | 160 | 15 | 3 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#5 | 2.21e-04 | 172 | 15 | 3 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 3.10e-04 | 489 | 15 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | 4.09e-04 | 973 | 15 | 5 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | 4.14e-04 | 976 | 15 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 4.18e-04 | 978 | 15 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.33e-04 | 44 | 15 | 2 | gudmap_kidney_adult_CortVasc_Tie2_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.94e-04 | 241 | 15 | 3 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 6.16e-04 | 244 | 15 | 3 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 6.35e-04 | 591 | 15 | 4 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 6.53e-04 | 249 | 15 | 3 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 6.55e-04 | 596 | 15 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 7.02e-04 | 607 | 15 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 9.18e-04 | 652 | 15 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | 9.33e-04 | 655 | 15 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.02e-03 | 290 | 15 | 3 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 | |
| CoexpressionAtlas | BM Top 100 - bronchus | 1.29e-03 | 76 | 15 | 2 | BM Top 100 - bronchus | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | 1.36e-03 | 78 | 15 | 2 | GSM605820_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.37e-03 | 726 | 15 | 4 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 | |
| CoexpressionAtlas | kidney | 1.39e-03 | 323 | 15 | 3 | kidney | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.40e-03 | 731 | 15 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.50e-03 | 744 | 15 | 4 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_k-means-cluster#3_top-relative-expression-ranked_500 | 1.68e-03 | 87 | 15 | 2 | gudmap_kidney_adult_GlomCapSys_Tie2_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#5 | 1.72e-03 | 88 | 15 | 2 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_500_K5 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 1.81e-03 | 783 | 15 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.03e-03 | 369 | 15 | 3 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.06e-03 | 371 | 15 | 3 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_500 | 2.13e-03 | 98 | 15 | 2 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_500 | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 3.90e-09 | 192 | 15 | 5 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | 5'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.21e-09 | 195 | 15 | 5 | 600174e35574fe7c44dd923adcf43686e7b01e39 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.55e-09 | 198 | 15 | 5 | a631be84e29c277216d89ec6265bd43e87c1dc86 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.92e-07 | 175 | 15 | 4 | 019ea30ac55748463d7917abf3d3f0e804189bfd | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 2.99e-07 | 176 | 15 | 4 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-07 | 178 | 15 | 4 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-07 | 188 | 15 | 4 | 315ce1736e3a84a63a8d5dfa70d411b501cb2532 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-07 | 190 | 15 | 4 | 4498705c5c1c7ba88a26fd2f412cf1aadd0f572a | |
| ToppCell | Enterocyte-C_05|Enterocyte / shred on cell type and cluster | 4.59e-07 | 196 | 15 | 4 | c307e5a70186567c62da938caa21749dc0e929d0 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 4.69e-07 | 197 | 15 | 4 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.78e-07 | 198 | 15 | 4 | efdbac7a3a02bff4ca48841772e0c136556c2b9b | |
| ToppCell | 5'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.78e-07 | 198 | 15 | 4 | db26c20321f9ab102d6484f22ddb2bde684067b1 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.88e-07 | 199 | 15 | 4 | 156354b799346d441dde42dbba09d7bde89ad460 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.98e-07 | 200 | 15 | 4 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.61e-06 | 82 | 15 | 3 | 42017b8ace6f142a8358213c95a2632226c3a867 | |
| ToppCell | (05)_Secretory-(1)_GFP|(05)_Secretory / shred by cell type by condition | 4.75e-06 | 100 | 15 | 3 | 838340a2b7c76f603e0ef2fe4fd170bd0dbce685 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.43e-06 | 121 | 15 | 3 | 2ae870f822488799cd0ad85e7f72af64e33a867f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.15e-05 | 134 | 15 | 3 | 657ad905b40ec3f82acdef824431b8276d291ef7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 138 | 15 | 3 | 2e46d546ad962aa0fde5b1c18c2a5370a4424e9f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 144 | 15 | 3 | 163c591fedad2beb7f92531e6240e9554f90ea40 | |
| ToppCell | VE-CD8-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 1.54e-05 | 148 | 15 | 3 | f49f579650b57cc4c6c7a7fa726447740d3dc695 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.64e-05 | 151 | 15 | 3 | 090b067873740c282865e2d02cf47d5cb3dd7607 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.67e-05 | 152 | 15 | 3 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 158 | 15 | 3 | 72e4f8ae137a7dddee0dc6236532e0711065e6af | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 158 | 15 | 3 | e1a8dba5a88bc3ce112829c5ecb112cbbee5b078 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 160 | 15 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 160 | 15 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Club_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.98e-05 | 161 | 15 | 3 | bd08a23b415617f6e8748ed2668d578a860ecf91 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-05 | 162 | 15 | 3 | 9c9a63adb692651ea5a52cc77b02c5ce11d0ccea | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 162 | 15 | 3 | dddf7a3901ae59e3494d8a6740db0fa15cc96d47 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-05 | 162 | 15 | 3 | 1d29983b22f963b34e72cfd1eec328d2d7c4932f | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 162 | 15 | 3 | 2a4e09545e9874519f0f56e81065104987d81cd6 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.21e-05 | 167 | 15 | 3 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-05 | 167 | 15 | 3 | f01b96173deda0239fa482989873cf308e49d48c | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.21e-05 | 167 | 15 | 3 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-05 | 167 | 15 | 3 | 5fc85a05124cd2324e1b8ff940193880f83cd8af | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.25e-05 | 168 | 15 | 3 | 32e4d82efaccf336d347e4063253c3635a3ec672 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.29e-05 | 169 | 15 | 3 | a0681317867e31319210a23e56660a53f4529efe | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-05 | 169 | 15 | 3 | 6937c46b119d4ce382fc8c2fa5925ede5ae89c81 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-05 | 169 | 15 | 3 | 58136b8a0bf2dab45c91a053ef7225ea49ccb871 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.29e-05 | 169 | 15 | 3 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-05 | 169 | 15 | 3 | 04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-05 | 169 | 15 | 3 | 0cece9b2bb1f58e465c20ec8735a4fc3c1021f03 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-05 | 170 | 15 | 3 | 9bea81031cdfe45e8cddac3a3afd9ca6c331c45a | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-05 | 170 | 15 | 3 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-05 | 170 | 15 | 3 | 2c5a1469e5743870e96e6c2cc92f0c5096b79f51 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.37e-05 | 171 | 15 | 3 | 48125d825ca2d7ef34564250f5b47d2a579e03c9 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.42e-05 | 172 | 15 | 3 | fc092a0631555d79e00ef9890cbd806e15bca2d4 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.42e-05 | 172 | 15 | 3 | 745725bd10c82017d678463b8fef0d2dcf09a8fd | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 173 | 15 | 3 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | (03)_Secretory-(0)_uninjured|(03)_Secretory / shred by cell type and Timepoint | 2.50e-05 | 174 | 15 | 3 | ebdddb5091afcc49ab533c890f260f709880c5f9 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.54e-05 | 175 | 15 | 3 | 4bfae78ac3a2cb9404382aae96d291504a9cfa14 | |
| ToppCell | Dendritic_Cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.54e-05 | 175 | 15 | 3 | 584290a51f9975782a5ac8c6ad67c778d8323f8c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.54e-05 | 175 | 15 | 3 | af9c5104c86231cfdb93a0f7d7032379efaa009e | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.54e-05 | 175 | 15 | 3 | f6a6db992e803d36c866a91706b02f67e0fd3e09 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-05 | 177 | 15 | 3 | 709235694cc711b9b79690e23c94577b2ae06811 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.63e-05 | 177 | 15 | 3 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.63e-05 | 177 | 15 | 3 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 177 | 15 | 3 | 6f6cf93893daac6ae228df36219ee3acf8de8f97 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-05 | 177 | 15 | 3 | 7f9c2a45a994b32f15e5693f7cb873716a4eb568 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.68e-05 | 178 | 15 | 3 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.68e-05 | 178 | 15 | 3 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.68e-05 | 178 | 15 | 3 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.68e-05 | 178 | 15 | 3 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | Club_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.68e-05 | 178 | 15 | 3 | be64d4be23fb96a4cdd7980c58880fdfe817747f | |
| ToppCell | Dendritic_Cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.68e-05 | 178 | 15 | 3 | 3a28103cf282cc3637d1875a3b4cd7ddf3207687 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.72e-05 | 179 | 15 | 3 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.72e-05 | 179 | 15 | 3 | c833ded1f9e87be2ba2037820d92a389560b711c | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.77e-05 | 180 | 15 | 3 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.77e-05 | 180 | 15 | 3 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.77e-05 | 180 | 15 | 3 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | facs-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 180 | 15 | 3 | 72310baeed848f2c483ae986cd73d2fb2cca7feb | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.86e-05 | 182 | 15 | 3 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.91e-05 | 183 | 15 | 3 | d1bf3abf42eb9d7facf775becf1338d1faadd647 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.91e-05 | 183 | 15 | 3 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 2.91e-05 | 183 | 15 | 3 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 2.91e-05 | 183 | 15 | 3 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.91e-05 | 183 | 15 | 3 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.91e-05 | 183 | 15 | 3 | bd78e5c2670e67b4363078e3ca5a5b7081d24b7e | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.91e-05 | 183 | 15 | 3 | fc9a7ba148c22d0c8a46f6bc56c772929ac496f7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 184 | 15 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-05 | 184 | 15 | 3 | 45ff845ceed5960a997545c1009012b65e377d50 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 184 | 15 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 184 | 15 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | mild-Myeloid-mDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.95e-05 | 184 | 15 | 3 | 8b37c00d59d9992d3b43268991da7bb94646c70e | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-05 | 184 | 15 | 3 | 2cc2646dee3c6001f7c10b7449c17d1935021958 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD163+CD14+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.95e-05 | 184 | 15 | 3 | 2dc4b2a9970111ed5e2977fc178595a12d7bb59d | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 2.95e-05 | 184 | 15 | 3 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.95e-05 | 184 | 15 | 3 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | Club|World / Class top | 3.00e-05 | 185 | 15 | 3 | c3caf789e622ed515d143dc594158d52fdcffaef | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-05 | 185 | 15 | 3 | d4ba36bdb8b7e3a62e827269484f89f790eaa5ef | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-05 | 186 | 15 | 3 | 4046b701aa29712d9f7c774f8955215122c3c003 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 186 | 15 | 3 | a7ab70b049742dfe7ee30557031bfac6412edf52 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.05e-05 | 186 | 15 | 3 | 1587667e5084ac43505d027af925ba711e228150 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.05e-05 | 186 | 15 | 3 | 37b93ebd64ebbd08193a746e5bc9b350c2570733 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.05e-05 | 186 | 15 | 3 | 219b1aeca17503244fabbb780bca58f22c7c0f27 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-05 | 186 | 15 | 3 | bd5837033c1ffcbe5dd30195cc4846a2ba351bcd | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 187 | 15 | 3 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 187 | 15 | 3 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 187 | 15 | 3 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| Computational | Trachea genes. | 3.19e-05 | 415 | 11 | 5 | MODULE_6 | |
| Computational | Placenta genes. | 8.80e-04 | 463 | 11 | 4 | MODULE_38 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.14e-03 | 50 | 11 | 2 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NOTCH_SIGNALING | |
| Drug | Methazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A | 6.61e-06 | 195 | 15 | 4 | 6268_UP | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 6.61e-06 | 195 | 15 | 4 | 6039_UP | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 7.31e-06 | 200 | 15 | 4 | 6029_UP | |
| Drug | lornoxicam | 8.49e-06 | 7 | 15 | 2 | ctd:C059451 | |
| Drug | diethylcarbamazine | 9.29e-05 | 22 | 15 | 2 | CID000003052 | |
| Drug | Lysophosphatidylcholines | 9.29e-05 | 22 | 15 | 2 | ctd:D008244 | |
| Drug | Trinitrobenzenesulfonic Acid | 1.06e-04 | 396 | 15 | 4 | ctd:D014302 | |
| Drug | retinoic acid; Up 200; 1uM; HL60; HT_HG-U133A | 1.09e-04 | 145 | 15 | 3 | 1152_UP | |
| Drug | AC1L9DJA | 1.11e-04 | 24 | 15 | 2 | CID000417411 | |
| Drug | pyrachlostrobin | 1.26e-04 | 811 | 15 | 5 | ctd:C513428 | |
| Drug | DIEP | 1.41e-04 | 27 | 15 | 2 | CID000114753 | |
| Drug | Phosgene | 1.54e-04 | 163 | 15 | 3 | ctd:D010705 | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Up 200; 10.4uM; PC3; HT_HG-U133A | 2.13e-04 | 182 | 15 | 3 | 6331_UP | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.23e-04 | 185 | 15 | 3 | 6243_UP | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.34e-04 | 188 | 15 | 3 | 5702_UP | |
| Drug | Lansoprazole [103577-45-3]; Down 200; 10.8uM; HL60; HT_HG-U133A | 2.38e-04 | 189 | 15 | 3 | 2967_DN | |
| Drug | Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.38e-04 | 189 | 15 | 3 | 6770_UP | |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.45e-04 | 191 | 15 | 3 | 3387_DN | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.49e-04 | 192 | 15 | 3 | 7378_DN | |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.53e-04 | 193 | 15 | 3 | 4676_UP | |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A | 2.57e-04 | 194 | 15 | 3 | 4838_UP | |
| Drug | Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.61e-04 | 195 | 15 | 3 | 3871_DN | |
| Drug | Gly-His-Lys acetate salt; Up 200; 1uM; PC3; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 6570_UP | |
| Drug | cellobiitol | 2.66e-04 | 37 | 15 | 2 | CID000003871 | |
| Drug | Cyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 5525_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 6741_DN | |
| Drug | Ioversol [87771-40-2]; Down 200; 5uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 3365_DN | |
| Drug | Chlorpropamide [94-20-2]; Down 200; 14.4uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 6291_DN | |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 5478_UP | |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 5611_UP | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 6446_UP | |
| Drug | Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 5545_DN | |
| Drug | rofecoxib; Down 200; 10uM; MCF7; HG-U133A | 2.73e-04 | 198 | 15 | 3 | 251_DN | |
| Drug | Metyrapone [54-36-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 6447_UP | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 2304_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 3707_UP | |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 3280_UP | |
| Drug | STOCK1N-28457; Up 200; 20uM; MCF7; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 6869_UP | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.81e-04 | 200 | 15 | 3 | 3896_DN | |
| Drug | histamine | 3.98e-04 | 560 | 15 | 4 | CID000000774 | |
| Drug | Cholecalciferol | 4.40e-04 | 233 | 15 | 3 | ctd:D002762 | |
| Drug | angiotensin (1-7) | 5.07e-04 | 51 | 15 | 2 | CID000123805 | |
| Drug | 2,4-diaminopyrimidine | 5.68e-04 | 54 | 15 | 2 | CID000067431 | |
| Drug | AC1O0B8G | 6.19e-04 | 262 | 15 | 3 | CID000091605 | |
| Drug | 5,8,11-eicosatriynoic acid | 7.01e-04 | 60 | 15 | 2 | CID000001781 | |
| Drug | Phenacetin | 7.49e-04 | 62 | 15 | 2 | ctd:D010615 | |
| Drug | myristyl acetate | 7.73e-04 | 63 | 15 | 2 | CID000012531 | |
| Drug | aristolochic acid | 8.48e-04 | 66 | 15 | 2 | CID000002236 | |
| Drug | dibenzothiophene | 9.89e-04 | 308 | 15 | 3 | ctd:C016366 | |
| Drug | Phosphorus | 1.24e-03 | 80 | 15 | 2 | ctd:D010758 | |
| Drug | 3-(phosphonomethyl)pyridine-2-carboxylic acid | 1.27e-03 | 81 | 15 | 2 | CID000001629 | |
| Drug | butyrate | 1.30e-03 | 767 | 15 | 4 | CID000000264 | |
| Drug | Ovalbumin | 1.31e-03 | 82 | 15 | 2 | ctd:D010047 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 3.76e-06 | 61 | 15 | 3 | DOID:3587 (is_marker_for) | |
| Disease | otitis media (is_marker_for) | 1.08e-05 | 10 | 15 | 2 | DOID:10754 (is_marker_for) | |
| Disease | pre-eclampsia (implicated_via_orthology) | 1.88e-05 | 13 | 15 | 2 | DOID:10591 (implicated_via_orthology) | |
| Disease | bipolar disorder (is_marker_for) | 4.10e-05 | 19 | 15 | 2 | DOID:3312 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.77e-04 | 64 | 15 | 2 | DOID:4947 (is_marker_for) | |
| Disease | Left-Sided Heart Failure | 1.40e-03 | 110 | 15 | 2 | C0023212 | |
| Disease | Myocardial Failure | 1.40e-03 | 110 | 15 | 2 | C1959583 | |
| Disease | Heart Failure, Right-Sided | 1.40e-03 | 110 | 15 | 2 | C0235527 | |
| Disease | Congestive heart failure | 1.40e-03 | 110 | 15 | 2 | C0018802 | |
| Disease | Heart failure | 1.40e-03 | 110 | 15 | 2 | C0018801 | |
| Disease | Heart Decompensation | 1.40e-03 | 110 | 15 | 2 | C1961112 | |
| Disease | asthma (is_marker_for) | 1.83e-03 | 126 | 15 | 2 | DOID:2841 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QHCCPQGYTCVAEGQ | 401 | P28799 | |
| GYCYNGACPTLAQQC | 501 | P78325 | |
| NYEIRVFCCNYGHCP | 2401 | Q9HC84 | |
| SCPVNYCYNQGHCYI | 5121 | Q99102 | |
| CINAGNTHYCQCPLG | 1126 | Q04721 | |
| ATCVQQGCACEGYQY | 56 | P98095 | |
| NCQYQCHETPYGGAC | 316 | P98164 | |
| CYYPCQHQGICVRFG | 36 | P23219 | |
| GQACVPIQQCGCYHN | 1576 | Q9Y6R7 | |
| NGQACVPIQQCGCYH | 2776 | Q9Y6R7 | |
| YNGQACVPIQQCGCY | 3976 | Q9Y6R7 | |
| CVPIQQCGCYHNGVY | 3981 | Q9Y6R7 | |
| YIPNNAYLHCQIGCC | 276 | P09913 | |
| QCICPVGYKGQFCQD | 381 | Q13753 | |
| ECRYGYCQQLCANVP | 171 | Q9UBX5 | |
| YCQQLCANVPGSYSC | 176 | Q9UBX5 | |
| THFCCPQYYCVCEPN | 2031 | Q3ZCN5 | |
| CPVCDGCEYQGHQYQ | 366 | Q6ZWJ8 | |
| QCVCPQGYVGYQCLS | 5141 | Q9UKN1 |